Annual Total Long Term Liabilities
$644.90 K
+$628.90 K+3930.63%
June 30, 2024
Summary
- As of February 7, 2025, INM annual total long term liabilities is $644.90 thousand, with the most recent change of +$628.90 thousand (+3930.63%) on June 30, 2024.
- During the last 3 years, INM annual total long term liabilities has risen by +$455.60 thousand (+240.68%).
- INM annual total long term liabilities is now at all-time high.
Performance
INM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$633.80 K
-$11.10 K-1.72%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly total long term liabilities is $633.80 thousand, with the most recent change of -$11.10 thousand (-1.72%) on September 30, 2024.
- Over the past year, INM quarterly long term liabilities has dropped by -$91.40 thousand (-12.60%).
- INM quarterly long term liabilities is now -68.36% below its all-time high of $2.00 million, reached on December 31, 2020.
Performance
INM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
INM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3930.6% | -12.6% |
| 3 y3 years | +240.7% | +62.7% |
| 5 y5 years | +100.0% | -68.4% |
INM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3930.6% | -21.1% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -68.4% | -100.0% |
| alltime | all time | at high | -100.0% | -68.4% | -100.0% |
InMed Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $633.80 K(-1.7%) |
| Jun 2024 | $644.90 K(+3930.6%) | $644.90 K(-11.1%) |
| Mar 2024 | - | $725.20 K(-9.7%) |
| Dec 2023 | - | $802.80 K(>+9900.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | $16.00 K(-95.9%) | $16.00 K(-78.0%) |
| Mar 2023 | - | $72.80 K(-60.4%) |
| Dec 2022 | - | $183.90 K(-37.5%) |
| Sep 2022 | - | $294.30 K(-24.4%) |
| Jun 2022 | $389.50 K(+105.8%) | $389.50 K(-21.1%) |
| Mar 2022 | - | $493.60 K(-17.5%) |
| Dec 2021 | - | $598.60 K(+235.2%) |
| Sep 2021 | - | $178.60 K(-5.7%) |
| Jun 2021 | $189.30 K(-23.7%) | $189.30 K(-12.4%) |
| Mar 2021 | - | $216.20 K(-89.2%) |
| Dec 2020 | - | $2.00 M(+750.2%) |
| Sep 2020 | - | $235.60 K(-5.0%) |
| Jun 2020 | $248.00 K(>+9900.0%) | $248.00 K(-3.5%) |
| Mar 2020 | - | $256.90 K(-13.1%) |
| Dec 2019 | - | $295.70 K(-4.5%) |
| Sep 2019 | - | $309.50 K(>+9900.0%) |
| Jun 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | - | $8200.00(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | $0.00 | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | - | $0.00(-100.0%) |
| Sep 2008 | - | $15.30 K(-36.0%) |
| Jun 2008 | $23.90 K(-40.1%) | $23.90 K(-24.6%) |
| Mar 2008 | - | $31.70 K(-29.6%) |
| Dec 2007 | - | $45.00 K(+26.1%) |
| Sep 2007 | - | $35.70 K(-10.5%) |
| Jun 2007 | $39.90 K(+3.4%) | $39.90 K(+47.8%) |
| Mar 2007 | - | $27.00 K(+0.7%) |
| Dec 2006 | - | $26.80 K(+6.8%) |
| Sep 2006 | - | $25.10 K(-35.0%) |
| Jun 2006 | $38.60 K(-61.9%) | $38.60 K(-16.6%) |
| Mar 2006 | - | $46.30 K(-21.1%) |
| Dec 2005 | - | $58.70 K(-32.7%) |
| Sep 2005 | - | $87.20 K(-14.0%) |
| Jun 2005 | $101.40 K(+288.5%) | $101.40 K(-87.8%) |
| Mar 2005 | - | $830.10 K(+3402.5%) |
| Dec 2004 | - | $23.70 K(+4.9%) |
| Sep 2004 | - | $22.60 K(-13.4%) |
| Jul 2004 | $26.10 K(-94.2%) | $26.10 K(-31.1%) |
| Apr 2004 | - | $37.90 K(-53.5%) |
| Jan 2004 | - | $81.50 K(-76.7%) |
| Oct 2003 | - | $349.30 K(-22.9%) |
| Jul 2003 | $453.00 K | $453.00 K |
FAQ
- What is InMed Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual total long term liabilities year-on-year change?
- What is InMed Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly long term liabilities year-on-year change?
What is InMed Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of INM is $644.90 K
What is the all time high annual total long term liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total long term liabilities is $644.90 K
What is InMed Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, INM annual total long term liabilities has changed by +$628.90 K (+3930.62%)
What is InMed Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of INM is $633.80 K
What is the all time high quarterly long term liabilities for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total long term liabilities is $2.00 M
What is InMed Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, INM quarterly total long term liabilities has changed by -$91.40 K (-12.60%)